R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.

Key actions by disease

 

News

All →

Documents

All →

Disease Commodity Packages - Ebola virus disease

Overview

last update: 21 September 2018

Editors
World Health Organization
Number of pages
4
Copyright
World Health Organization

Publications

All →
Third meeting of the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo virus disease outbreak response: meeting report, 31 July 2026

This meeting report summarizes the deliberations and recommendations of the third meeting of the WHO Technical Advisory Group on Candidate Vaccine Prioritization...

WHO target product profile for Bundibugyo virus disease vaccines, 14 July 2026

Bundibugyo virus disease, which is caused by Bundibugyo virus, is a severe filovirus infection with epidemic potential that requires the development of...

WHO Technical Advisory Group on Candidate Vaccine Prioritization: meeting report, 19 and 25 May 2026

This meeting report summarizes the deliberations and recommendations of the WHO Technical Advisory Group on Candidate Vaccine Prioritization (TAG-CVP)...

Related health topics